A carregar...
Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in HSV-2 seropositive women
OBJECTIVE: Oral tenofovir-based pre-exposure prophylaxis (PrEP) is an important tool for prevention of new HIV infections, which also reduces subclinical HSV-2 shedding and symptomatic lesions in HIV-negative, HSV-2-seropositive individuals. However, the impact of PrEP on mucosal immunity has not be...
Na minha lista:
| Publicado no: | AIDS |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6832814/ https://ncbi.nlm.nih.gov/pubmed/31335802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002323 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|